Montreal, Quebec, Canada - September 4, 2012 (Investorideas.com Newswire) Sunshine Biopharma Inc. (OTCBB:SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has taken delivery of an initial batch of Adva-27a from the Contract Manufacturing Organization (CMO) and has proceeded to conducting a series of requisite biological tests to ensure that the newly manufactured batch is identical to the original, not only in terms of chemical structure but also in terms of biological activity. Among the tests we will be performing are Topoisomerase II inhibition assays and cytotoxicity evaluations. The Topoisomerase II inhibition tests are already underway and the cytotoxicity evaluations will be initiated later this week. Adva-27a is Sunshine Biopharma’s lead anti-cancer compound which has proven effective at killing Multidrug Resistant Breast Cancer cells (MCF-7/MDR) and Small-Cell Lung Cancer cells (H69AR).

Read more: Biotech Stock Alert: SUNSHINE BIOPHARMA (OTCBB:SBFM) TAKES DELIVERY OF NEWLY MANUFACTURED BATCH OF...

New York, New York - August 24, 2012 (www,investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector for independent investors reports on the top five percentage gainers on the NASDAQ for Friday August 24th.

Aruba Networks, Inc. (NASDAQ:ARUN) is trading up at $ 20.05, gaining $ 3.13 or 18.50% on volume of 5,527,338. The stock moved on record fourth quarter and fiscal 2012 year results .The Company reported revenue for Q4’12 of $139.2 million, an increase of 22 percent from the $113.8 million reported in Q4’11. GAAP net loss for Q4’12 was $3.0 million, or $0.03 per share, compared with GAAP net income of $68.2 million, or $0.57 per share, in Q4’11.

Read more: Friday's NASDAQ Morning Movers; ARUN, UEPS, ONTY, MCRS, GERN

Terraco Gold (TEN TSXV)

Fall is in the air here in northern New Jersey today. It is change of seasons after a blazing hot summer.

It has been a summer of discontent amongst the junior resource sector.

It is hard to explain value when the market for the “Penny Dreadful” (and there are a lot of them) simply does not want to recognize value, or to care. This market is scared. However we see a bottom and a turn in the TSXV index that will coincide with the fall and the colour that is coming.

Take a look at the recent meanderings of the Canadian Venture index (composed mostly of resource stocks). You have to like everything about this chart because it sure does look like a bottom is in. That will be good for so many of these juniors that are struggling at present.

Written by Michael A. Berry, Ph.D. - [ Discovery Investing Web Site ]

alt

SAN DIEGO - August 23, 2012 (Investorideas.com newswire) - Biodfense stock news;Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that the Wall Street Transcript has conducted an interview with its Chairman and CEO, Jim Joyce. The full interview is now available to be accessed online at: http://aethlonmedical. investorroom.com/ index.php?s=19.

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Read more: Biotech Stock News; Aethlon Medical (OTCBB: AEMD) Discusses Therapeutic Device Strategies to...

DELRAY BEACH, Fla. - August 23, 2012 - (Investorideas.com Newswire) PositiveID Corporation (OTCBB: PSID) ("PositiveID" or "Company"), an emerging growth company and developer of sophisticated airborne bio-threat detection systems for America's homeland security, today announced a mid-year update and the significant progress it has made realigning its business with a focus on its molecular diagnostics platform. The Company also continues to make strong progress in the diabetes management segment of its business.

Read more: Biodefense Stock News; PositiveID Corporation (OTCBB: PSID) Provides Mid-Year Update to Stockholders